Core Laboratory Collaboration for Research, Innovation, and Translation
NBIIC-HI collaborates with Nankai University through a core laboratory framework designed to support international research cooperation, academic exchange, interdisciplinary project development, and responsible translation.
Built on shared interests in life sciences, biomedical research, and healthcare innovation, the collaboration connects scientific expertise, technical capabilities, talent development, and international partnership opportunities.
The Core Laboratory provides a long-term platform for collaborative research, innovation development, technical cooperation, and future translational initiatives.
Nankai University is a major research university in China with established strengths in life sciences, biomedical research, chemistry, and interdisciplinary scientific innovation. Through this Core Laboratory collaboration, NBIIC-HI and Nankai University seek to advance:
This collaboration supports NBIIC-HI's broader institutional value chain:
By connecting academic research, innovation development, clinical relevance, and international partnerships, the collaboration provides a foundation for responsible and sustainable healthcare impact.
Through this collaboration, NBIIC-HI and its partners continue to strengthen an international platform connecting research, innovation, clinical collaboration, global partnerships, and healthcare impact.
As a technical component of the Core Laboratory collaboration, the Nanomedicine & Bioconjugation Technical Collaboration Platform supports translational biomedical research, early-stage innovation, technical development, and preclinical validation.
Through this platform, NBIIC-HI coordinates international project development, clinical and scientific needs assessment, partner engagement, research communication, and translation planning, while participating technical teams provide specialized experimental and validation capabilities in China.
The platform supports research teams working in nanomedicine, targeted drug delivery, LNP and RNA delivery, exosome engineering, molecular imaging, smart biomaterials, bioconjugation, preclinical validation, and customized research-use-only assay and kit development.
This brochure provides further information on technical capabilities, customized research-use-only assay and kit development, preclinical validation services, and available international collaboration models.
This platform supports research and preclinical collaboration. Clinical activities, patient-related services, regulated product development, and commercialization are subject to the approvals, governance, and responsibilities of appropriately authorized institutions.
NBIIC-HI welcomes discussions with researchers, universities, research institutions, clinical teams, technical platforms, and innovation partners interested in developing related research, technical, or translational collaborations through appropriate institutional frameworks.
Where appropriate, NBIIC-HI may also help participating teams position and communicate their technologies, technical capabilities, and research services, and connect them with suitable academic, clinical, institutional, and international partners to support validation, collaborative development, broader visibility, and responsible translation.
